ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $712,000 | -12.1% | 205,193 | +6.2% | 0.00% | 0.0% |
| Q3 2014 | $810,000 | -22.8% | 193,226 | +7.9% | 0.00% | 0.0% |
| Q2 2014 | $1,049,000 | +19.2% | 179,042 | +28.2% | 0.00% | 0.0% |
| Q1 2014 | $880,000 | -68.7% | 139,668 | -70.9% | 0.00% | -66.7% |
| Q4 2013 | $2,811,000 | +10.9% | 480,542 | -0.1% | 0.00% | 0.0% |
| Q3 2013 | $2,535,000 | +90.2% | 481,062 | +177.8% | 0.00% | +50.0% |
| Q2 2013 | $1,333,000 | – | 173,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |